Published in N Engl J Med on October 21, 2004
Treatment With Tamoxifen in Cryptococcal Meningitis | NCT03112031
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med (2014) 6.65
Combination antifungal therapy for cryptococcal meningitis. N Engl J Med (2013) 4.87
Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology (2011) 4.63
The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog (2008) 3.79
The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell (2010) 3.64
Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis. N Engl J Med (2016) 3.59
Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell (2012) 3.54
PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology (2009) 3.37
Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev (2008) 2.88
Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS (2010) 2.83
TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell (2013) 2.71
Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis. Clin Infect Dis (2011) 2.70
Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance. Clin Infect Dis (2009) 2.66
Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther (2007) 2.65
Neuroimaging of infections. NeuroRx (2005) 2.34
Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol (2008) 1.89
A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J Infect Dis (2006) 1.83
Central nervous system tuberculosis. Afr Health Sci (2011) 1.83
Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ (2010) 1.77
Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol (2007) 1.77
Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol (2013) 1.62
Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults. PLoS One (2008) 1.51
Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol (2006) 1.47
Adjunctive steroids for tuberculous meningitis--more evidence, more questions. N Engl J Med (2004) 1.44
General principles of antimicrobial therapy. Mayo Clin Proc (2011) 1.42
A scoring system to effectively evaluate central nervous system tuberculosis in patients with military tuberculosis. PLoS One (2017) 1.38
Challenges in the diagnosis & treatment of miliary tuberculosis. Indian J Med Res (2012) 1.37
Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis (2012) 1.35
Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul) (2015) 1.32
Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. Am J Respir Crit Care Med (2014) 1.29
Changing paradigms in Whipple's disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis (2011) 1.28
Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med (2012) 1.25
Pathogenesis of central nervous system tuberculosis. Curr Mol Med (2009) 1.22
Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis. J Immunol (2012) 1.21
Central nervous system immune reconstitution inflammatory syndrome. Curr Infect Dis Rep (2013) 1.21
Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther (2011) 1.20
Aetiologies of central nervous system infection in Viet Nam: a prospective provincial hospital-based descriptive surveillance study. PLoS One (2012) 1.18
Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. PLoS One (2011) 1.18
Tuberculous meningitis: diagnosis and treatment overview. Tuberc Res Treat (2011) 1.17
Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis. PLoS One (2007) 1.14
Retracted Diagnosis and management of miliary tuberculosis: current state and future perspectives. Ther Clin Risk Manag (2013) 1.13
Diagnosis of central nervous system tuberculosis by T-cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Vaccine Immunol (2008) 1.11
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrob Agents Chemother (2011) 1.10
The spectrum of central nervous system infections in an adult referral hospital in Hanoi, Vietnam. PLoS One (2012) 1.09
Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis. PLoS One (2011) 1.09
Tuberculous meningitis in HIV-infected individuals. Curr HIV/AIDS Rep (2009) 1.08
Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis. PLoS One (2009) 1.07
The PCR-Based Diagnosis of Central Nervous System Tuberculosis: Up to Date. Tuberc Res Treat (2012) 1.06
Tuberculous meningitis. N Engl J Med (2004) 1.04
Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis. Clin Vaccine Immunol (2011) 1.04
Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents. PLoS One (2011) 1.02
Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review. BMC Med (2013) 1.01
Global research priorities for infections that affect the nervous system. Nature (2015) 1.01
Predictors and outcome of patients with acute respiratory distress syndrome caused by miliary tuberculosis: a retrospective study in Chongqing, China. BMC Infect Dis (2012) 1.00
Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med (2015) 1.00
Autophagy in the immune response to tuberculosis: clinical perspectives. Clin Exp Immunol (2011) 1.00
A fatal case of spinal tuberculosis mistaken for metastatic lung cancer: recalling ancient Pott's disease. Ann Clin Microbiol Antimicrob (2009) 0.98
Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol Mol Biol Rev (2013) 0.97
PPE38 modulates the innate immune response and is required for Mycobacterium marinum virulence. Infect Immun (2011) 0.97
B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunol Rev (2015) 0.97
HIV-1 and the immune response to TB. Future Virol (2013) 0.97
Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis. BMC Infect Dis (2016) 0.97
Tuberculous meningitis in adults: a review of 160 cases. ScientificWorldJournal (2012) 0.96
Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients. Clin Infect Dis (2011) 0.95
Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: development and methodology. J Clin Microbiol (2008) 0.95
Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. J Infect Dis (2012) 0.94
Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev (2016) 0.93
Tag SNP polymorphism of CCL2 and its role in clinical tuberculosis in Han Chinese pediatric population. PLoS One (2011) 0.92
TB: the Yin and Yang of lipid mediators. Curr Opin Pharmacol (2013) 0.91
A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa. J Neurol (2013) 0.90
Mortality associated with central nervous system tuberculosis. J Infect (2007) 0.90
Meningitis in HIV-positive patients in sub-Saharan Africa: a review. J Int AIDS Soc (2014) 0.90
Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis. Antimicrob Agents Chemother (2012) 0.89
Comparison of real time IS6110-PCR, microscopy, and culture for diagnosis of tuberculous meningitis in a cohort of adult patients in Indonesia. PLoS One (2012) 0.89
Presentation and outcome of tuberculous meningitis in adults in the province of Castellon, Spain: a retrospective study. Epidemiol Infect (2008) 0.88
Therapy duration and long-term outcomes in extra-pulmonary tuberculosis. BMC Infect Dis (2014) 0.87
Fit for consumption: zebrafish as a model for tuberculosis. Dis Model Mech (2014) 0.86
Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma. Immunol Rev (2015) 0.86
Tuberculous meningitis in patients infected with human immunodeficiency virus. J Neurol (2010) 0.86
Clinical review: a systematic review of corticosteroid use in infections. Crit Care (2006) 0.86
Paradoxical Manifestation is Common in HIV-negative Tuberculous Meningitis. Medicine (Baltimore) (2016) 0.85
Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: clinical application for diagnosis of tuberculous meningitis. J Clin Microbiol (2008) 0.85
Cerebrospinal fluid cytokines and matrix metalloproteinases in human immunodeficiency seropositive and seronegative patients of tuberculous meningitis. Ann Indian Acad Neurol (2014) 0.85
Clinical review: tuberculosis on the intensive care unit. Crit Care (2013) 0.85
Association between neuromyelitis optica and tuberculosis in a Chinese population. BMC Neurol (2014) 0.85
Mycobacterium tuberculosis-infected human monocytes down-regulate microglial MMP-2 secretion in CNS tuberculosis via TNFα, NFκB, p38 and caspase 8 dependent pathways. J Neuroinflammation (2011) 0.85
Diagnosis of tuberculous meningitis due to detection of ESAT-6-specific gamma interferon production in cerebrospinal fluid enzyme-linked immunospot assay. Clin Vaccine Immunol (2008) 0.84
Vasospasm in cerebral inflammation. Int J Inflam (2014) 0.84
Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis (2014) 0.83
Neurological complications after tuberculous meningitis in a multi-state cohort in the United States. J Neurol Sci (2017) 0.83
Quantitative proteomics for identifying biomarkers for tuberculous meningitis. Clin Proteomics (2012) 0.82
Vaccination with recombinant Mycobacterium tuberculosis PknD attenuates bacterial dissemination to the brain in guinea pigs. PLoS One (2013) 0.82
Spinal cord involvement in tuberculous meningitis. Spinal Cord (2015) 0.81
Are steroids a beneficial adjunctive therapy in the immunosuppressed patient with herpes simplex virus encephalitis? Case Rep Neurol (2013) 0.81
Medical management of genitourinary tuberculosis. Indian J Urol (2008) 0.81
Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections. MBio (2016) 0.81
Cerebral tuberculoma in a patient receiving anti-TNF alpha (adalimumab) treatment. Clin Rheumatol (2010) 0.81
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
The global distribution and burden of dengue. Nature (2013) 27.92
Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med (2005) 15.53
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet (2005) 12.98
Typhoid fever. N Engl J Med (2002) 12.96
Avian influenza A (H5N1) infection in humans. N Engl J Med (2005) 12.95
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet (2012) 11.82
Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med (2004) 11.31
Dengue. N Engl J Med (2012) 10.45
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (2010) 8.52
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med (2005) 8.36
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis (2012) 6.94
Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med (2005) 6.47
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol (2006) 6.34
A major genome region underlying artemisinin resistance in malaria. Science (2012) 6.25
Mixed-species malaria infections in humans. Trends Parasitol (2004) 6.01
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One (2009) 5.81
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J (2011) 5.65
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med (2007) 5.12
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med (2005) 4.65
Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg (2007) 4.58
Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A (2010) 4.50
Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med (2005) 4.47
Manslaughter by fake artesunate in Asia--will Africa be next? PLoS Med (2006) 4.46
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis (2007) 4.35
Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J (2008) 4.33
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J (2009) 4.25
An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med (2010) 4.24
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis (2006) 4.14
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet (2004) 4.14
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis. N Engl J Med (2016) 4.11
Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci U S A (2012) 4.10
Early origin and recent expansion of Plasmodium falciparum. Science (2003) 4.07
Counterfeit anti-infective drugs. Lancet Infect Dis (2006) 3.91
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet (2006) 3.90
Rickettsial infections and fever, Vientiane, Laos. Emerg Infect Dis (2006) 3.87
High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis (2010) 3.81
The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog (2008) 3.79
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet (2004) 3.72
The WHO dengue classification and case definitions: time for a reassessment. Lancet (2006) 3.69
A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. Mol Biol Evol (2003) 3.67
Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell (2012) 3.54
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis (2002) 3.46
Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nat Genet (2012) 3.22
Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis (2010) 3.21
The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med (2005) 3.15
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin Infect Dis (2005) 3.15
In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J (2012) 3.13
How much fat is necessary to optimize lumefantrine oral bioavailability? Trop Med Int Health (2007) 3.13
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis (2010) 3.08
Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis (2012) 3.06
The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis (2008) 3.05
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin Infect Dis (2009) 3.05
How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health (2005) 2.95
Tuberculous meningitis: many questions, too few answers. Lancet Neurol (2005) 2.90
Enteropathogens and chronic illness in returning travelers. N Engl J Med (2013) 2.89
Spurious amplification of a Plasmodium vivax small-subunit RNA gene by use of primers currently used to detect P. knowlesi. J Clin Microbiol (2009) 2.85
Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. J Infect Dis (2004) 2.82
Central role of the spleen in malaria parasite clearance. J Infect Dis (2002) 2.80
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother (2004) 2.77
Antimalarial drug toxicity: a review. Drug Saf (2004) 2.76
Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. Virology (2002) 2.75
Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol (2010) 2.74
A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol (2007) 2.71
Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J (2009) 2.70
Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob Agents Chemother (2010) 2.68
Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Trop Dis (2010) 2.68
A dominant clone of Leptospira interrogans associated with an outbreak of human leptospirosis in Thailand. PLoS Negl Trop Dis (2007) 2.65
Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol (2004) 2.60
Counterfeit artesunate antimalarials in southeast Asia. Lancet (2003) 2.59